Role of the microbiota and antibiotics in primary sclerosing cholangitis (Q42174395)

18 October 2017

1 reference

21 January 2021

Role of the microbiota and antibiotics in primary sclerosing cholangitis (English)

1 reference

inflammatory bowel diseases

18 October 2017

1 reference

primary sclerosing cholangitis

21 January 2021

sclerosing cholangitis

1 reference

21 January 2021

1 reference

16 September 2019

1 reference

11 September 2020

1 reference

James H Tabibian

1

1 reference

18 October 2017

Jayant A Talwalkar

series ordinal

2

1 reference

18 October 2017

Keith D Lindor

series ordinal

3

1 reference

18 October 2017

language of work or name

English

0 references

publication date

22 October 2013

7 references

BioMed Research International

18 October 2017

21 March 2019

22 June 2019

20 June 2019

16 September 2019

11 September 2020

21 January 2021

7 references

18 October 2017

21 March 2019

22 June 2019

20 June 2019

16 September 2019

11 September 2020

21 January 2021

2013

1 reference

18 October 2017

389537

1 reference

Creative Commons Attribution 3.0 Unported

18 October 2017

6 references

21 March 2019

22 June 2019

20 June 2019

16 September 2019

11 September 2020

on focus list of Wikimedia project

21 January 2021

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Physiology of cholangiocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Micro-computed tomography and nuclear magnetic resonance imaging for noninvasive, live-mouse cholangiography

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Successful treatment of recurrent primary sclerosing cholangitis after orthotopic liver transplantation with oral vancomycin

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Primary sclerosing cholangitis: a review and update on therapeutic developments

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

The dynamic biliary epithelia: molecules, pathways, and disease

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Immunomodulatory effect of vancomycin on Treg in pediatric inflammatory bowel disease and primary sclerosing cholangitis

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases.

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Successful treatment of primary sclerosing cholangitis with a steroid and a probiotic

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

The impact of the gut microbiota on human health: an integrative view

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Primary sclerosing cholangitis: etiopathogenesis and clinical management

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotype

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Cholangiopathy with respect to biliary innate immunity

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

The intestinal microbiota and chronic disorders of the gut

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Cholangiocyte N-Ras protein mediates lipopolysaccharide-induced interleukin 6 secretion and proliferation

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Will we ever model PSC? - "it's hard to be a PSC model!".

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Live donor liver transplantation for primary sclerosing cholangitis: is disease recurrence increased?

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Antibiotics for the treatment of primary sclerosing cholangitis

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

The immunobiology of cholangiocytes

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

The challenges in primary sclerosing cholangitis--aetiopathogenesis, autoimmunity, management and malignancy

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Liver transplantation in primary sclerosing cholangitis

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Etiopathogenesis of primary sclerosing cholangitis

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation?

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Immunopathogenesis of primary sclerosing cholangitis

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Primary sclerosing cholangitis; review and report of six cases

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Primary sclerosing cholangitis in Japanese patients: association with inflammatory bowel disease

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Small duct cholangitis induced by N-formyl L-methionine L-leucine L-tyrosine in rats

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Role of hepatocytes in direct clearance of lipopolysaccharide in rats

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Primary sclerosing cholangitis, the biliary tree, and ulcerative colitis

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Degradation of endogenous bacterial cell wall polymers by the muralytic enzyme mutanolysin prevents hepatobiliary injury in genetically susceptible rats with experimental intestinal bacterial overgrowth

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

The role of dominant stenoses in bacterial infections of bile ducts in primary sclerosing cholangitis

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Intestinal permeability in patients with Crohn's disease and their healthy relatives

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Enhanced innate immune responsiveness and intolerance to intestinal endotoxins in human biliary epithelial cells contributes to chronic cholangitis.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Diagnosis and management of primary sclerosing cholangitis

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

De-novo cholangiocarcinoma in native common bile duct remnant following OLT for primary sclerosing cholangitis

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Minocycline in the treatment of patients with primary sclerosing cholangitis: results of a pilot study

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Probiotics in primary sclerosing cholangitis: a randomized placebo-controlled crossover pilot study

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibiotic

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Azithromycin may reduce cholestasis in primary sclerosing cholangitis: a case report and serendipitous observation

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Human intrahepatic biliary epithelial cells function in innate immunity by producing IL-6 and IL-8 via the TLR4-NF-kappaB and -MAPK signaling pathways.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Multiple TLRs are expressed in human cholangiocytes and mediate host epithelial defense responses to Cryptosporidium parvum via activation of NF-kappaB.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Intestinal permeability and bacterial growth of the small bowel in patients with primary sclerosing cholangitis

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Increased intestinal permeability in patients with inflammatory bowel disease.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Oral vancomycin: treatment of primary sclerosing cholangitis in children with inflammatory bowel disease

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3819830

Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis

17 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155/2013/389537

Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1155/2013/389537

Effect of long-term tetracycline therapy, steroid therapy and colectomy in pericholangitis associated with ulcerative colitis

21 January 2018

1 reference

12 December 2020

The liver in ulcerative colitis; treatment of pericholangitis with tetracycline

1 reference

12 December 2020

Update on primary sclerosing cholangitis

1 reference

12 December 2020

A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts

1 reference

12 December 2020

A microcholangiographic study of liver disease models in rats

1 reference

12 December 2020

Biliary tract disease in rats with experimental small bowel bacterial overgrowth

1 reference

12 December 2020

Long-term bacterial exposure can trigger nonsuppurative destructive cholangitis associated with multifocal epithelial inflammation

1 reference

12 December 2020

Lipopolysaccharides and Beta-Glucuronidase Activity in Choledochal Bile in Relation to Choledocholithiasis

1 reference

12 December 2020

Three paediatric cases of primary sclerosing cholangitis treated with ursodeoxycholic acid and sulphasalazine

1 reference

12 December 2020

Therapeutic benefit of sulfasalazine for patients with primary sclerosing cholangitis

1 reference

12 December 2020

Amplification and sequence analysis of partial bacterial 16S ribosomal RNA gene in gallbladder bile from patients with primary biliary cirrhosis

1 reference

12 December 2020

Primary sclerosing cholangitis: the gut-liver axis

1 reference

12 December 2020

Metronidazole in primary cholangitis

1 reference

12 December 2020

Abnormal accumulation of endotoxin in biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis

1 reference

12 December 2020

Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis - a pilot study

1 reference

12 December 2020

Identifiers

DOI

10.1155/2013/389537

1 reference

18 October 2017

1 reference

18 October 2017

PubMed publication ID

24232746

1 reference